Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
26.99
-1.63 (-5.70%)
At close: Apr 28, 2026, 4:00 PM EDT
27.39
+0.40 (1.48%)
After-hours: Apr 28, 2026, 6:49 PM EDT
Immunovant Market Cap
Immunovant has a market cap or net worth of $5.49 billion as of April 28, 2026. Its market cap has increased by 118.66% in one year.
Market Cap
5.49B
Enterprise Value
4.53B
1-Year Change
118.66%
Ranking
Category
Stock Price
$26.99
Market Cap Chart
Since June 21, 2019, Immunovant's market cap has increased from $124.38M to $5.49B, an increase of 4,316.75%. That is a compound annual growth rate of 73.78%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spyre Therapeutics | 6.20B |
| Terns Pharmaceuticals | 6.11B |
| Centessa Pharmaceuticals | 6.11B |
| Celcuity | 6.07B |
| Erasca | 5.95B |
| Cogent Biosciences | 5.90B |
| Rhythm Pharmaceuticals | 5.82B |
| PTC Therapeutics | 5.74B |